華神科技(000790.SZ):遠泓生物累計減持1.47%股份
格隆匯7月16日丨華神科技(000790.SZ)公佈,公司近日收到公司股東成都遠泓生物科技有限公司(簡稱“遠泓生物”)的《關於減持股份的吿知函》,遠泓生物於2025年5月14日至2025年7月16日通過深圳證券交易所集中競價交易方式累計減持其直接持有的公司股份9,140,000股,佔公司總股本的1.47%,減持股份來源於其通過深圳證券交易所集中競價交易方式買入的公司股票。
遠泓生物為公司間接控股股東,其持有公司控股股東四川華神集團股份有限公司(以下簡稱“四川華神”)85.99%的股份。本次減持前,遠泓生物直接持有公司股份9,140,000股,四川華神持有公司股份111,431,281股,遠泓生物及四川華神合計持有公司股份120,571,281股,佔公司總股本的19.33%。本次減持後,遠泓生物不再直接持有公司股份,四川華神持有公司股份111,431,281股,佔公司總股本的17.87%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.